Benitec Biopharma Ltd ADR Working Capital to Net Assets Ratio
Benitec Biopharma Ltd ADR working capital to net assets ratio. Benitec Biopharma Ltd ADR (BNTC) has a Working Capital to Net Assets ratio of 99.7% as of December 2025. Working capital of $186.79 Million (current assets of $189.59 Million minus current liabilities of $2.80 Million) is measured against net assets of $187.36 Million. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Benitec Biopharma Ltd ADR (2013–2025)
Working capital to net assets ratio of Benitec Biopharma Ltd ADR from 2013 to 2025. This chart shows how Benitec Biopharma Ltd ADR's Working Capital to Net Assets ratio has evolved across 13 annual periods from 2013 to 2025. As of December 2025, the ratio stands at 99.7%, reflecting working capital of $186.79 Million against net assets of $187.36 Million USD. See BNTC days of operational coverage to measure how many days the company can operate on defensive assets alone.
Benitec Biopharma Ltd ADR Working Capital to Net Assets Ratio by Year (2013–2025)
Benitec Biopharma Ltd ADR working capital to net assets ratio by year from 2013 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Benitec Biopharma Ltd ADR from 2013 to 2025, covering 13 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Benitec Biopharma Ltd ADR total assets.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 99.4% | $96.72 Million | $97.30 Million | $98.52 Million | $1.80 Million | ▲ +0.5 pp |
| 2024 | 98.9% | $46.75 Million | $47.25 Million | $51.67 Million | $4.92 Million | ▲ +222.2 pp |
| 2023 | -123.3% | $-249.00K | $202.00K | $3.73 Million | $3.98 Million | ▼ -202.7 pp |
| 2022 | 79.4% | $2.29 Million | $2.88 Million | $4.82 Million | $2.53 Million | ▼ -16.8 pp |
| 2021 | 96.1% | $19.24 Million | $20.01 Million | $20.61 Million | $1.37 Million | ▲ +1.7 pp |
| 2020 | 94.5% | $9.67 Million | $10.24 Million | $10.81 Million | $1.14 Million | ▼ -2.6 pp |
| 2019 | 97.1% | $16.09 Million | $16.57 Million | $18.73 Million | $2.64 Million | ▼ -0.8 pp |
| 2018 | 97.9% | $13.48 Million | $13.77 Million | $15.35 Million | $1.87 Million | ▲ +0.1 pp |
| 2017 | 97.8% | $16.17 Million | $16.53 Million | $17.03 Million | $864.51K | ▲ +0.4 pp |
| 2016 | 97.4% | $13.70 Million | $14.07 Million | $14.48 Million | $772.92K | ▼ -0.7 pp |
| 2015 | 98.1% | $17.96 Million | $18.31 Million | $19.22 Million | $1.26 Million | ▲ +0.0 pp |
| 2014 | 98.1% | $22.05 Million | $22.48 Million | $23.60 Million | $1.55 Million | ▼ -1.8 pp |
| 2013 | 99.9% | $30.57 Million | $30.61 Million | $31.44 Million | $871.53K | — |